Clinical Trials for the Effects of Polygoni Multiflori Radix Complex Extract on Memory Improvement

Sponsor
Korean Medicine Hospital of Pusan National University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02401646
Collaborator
(none)
54
1
2
9
6

Study Details

Study Description

Brief Summary

The aim of this study is to identify the effect of Polygoni Multiflori Radix complex extract on memory improvement using Rey-Kim scale for healthy people.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Polygoni Multiflori Radix complex extract
  • Dietary Supplement: Placebo
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Clinical Trials for the Effects of Polygoni Multiflori Radix Complex Extract on Memory Improvement
Study Start Date :
Mar 1, 2015
Anticipated Primary Completion Date :
Nov 1, 2015
Anticipated Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Polygoni Multiflori Radix complex

Participants randomized to the experimental group will take one capsule of Polygoni Multiflori Radix complex extract (250mg) twice a day, 30 minutes after breakfast and dinner for 4 weeks.

Dietary Supplement: Polygoni Multiflori Radix complex extract
Intervention is manufactured by Chun-Ho food

Placebo Comparator: Starch

Participants randomized to the placebo group will take one capsule of placebo(250mg) twice a day, 30 minutes after breakfast and dinner for 4 weeks.

Dietary Supplement: Placebo
The placebo is filled with starch, so does not contain the active ingredient.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline on Memory Quotient score at 2 weeks and 4 weeks [baseline, at 2 weeks after taking experimental or placebo dietary supplement, at 4 weeks after taking supplement]

Secondary Outcome Measures

  1. Change from baseline in Memory registration at 2 weeks and 4 weeks [baseline, at 2 weeks after taking experimental or placebo dietary supplement, at 4 weeks after taking supplement]

    Rey-Kim scale is a tool to assess the short-term memory. It is composed of AVLT and CFT. # AVLT After tester speaks each 15 word, subjects are asked to tell all words immediately as memory serves. This process is repeated 5 times (Each process is called AVLT process 1-5 according to priority). After 20 minutes interval, subjects are also asked to tell all words they can remember (AVLT process 6). Right after that, subjects should select the words they heard among 35 words (AVLT process 7). Memory registration is calculated by converting score difference into a percentage between AVLT process 1 and 5 mentioned above.

  2. Change from baseline in Memory retention at 2 weeks and 4 weeks [baseline, at 2 weeks after taking experimental or placebo dietary supplement, at 4 weeks after taking supplement]

    # AVLT After tester speaks each 15 word, subjects are asked to tell all words immediately as memory serves. This process is repeated 5 times (Each process is called AVLT process 1-5 according to priority). After 20 minutes interval, subjects are also asked to tell all words they can remember (AVLT process 6). Right after that, subjects should select the words they heard among 35 words (AVLT process 7). Memory retention is calculated by converting score difference into a percentage between AVLT process 5 and 6 mentioned above.

  3. Change from baseline in Retrieval efficiency at 2 weeks and 4 weeks [baseline, at 2 weeks after taking experimental or placebo dietary supplement, at 4 weeks after taking supplement]

    # AVLT After tester speaks each 15 word, subjects are asked to tell all words immediately as memory serves. This process is repeated 5 times (Each process is called AVLT process 1-5 according to priority). After 20 minutes interval, subjects are also asked to tell all words they can remember (AVLT process 6). Right after that, subjects should select the words they heard among 35 words (AVLT process 7). Retrieval efficiency is calculated by converting score difference into a percentage between AVLT process 6 and 7 mentioned above.

  4. Change from baseline in Copy-recall difference index at 2 weeks and 4 weeks [baseline, at 2 weeks after taking experimental or placebo dietary supplement, at 4 weeks after taking supplement]

    Rey-Kim scale is a tool to assess the short-term memory. It is composed of AVLT and CFT. # CFT After tester shows subjects very complicated figure, subjects are asked to copy it (CFT process 1). Right after that, subjects should draw the figure as memory serves (CFT process 2). After 20 minutes interval, subjects are also asked to select the part of figure they copy among various figures (CFT process 3). Copy-recall difference index is calculated by converting score difference into a percentage between CFT process 1 and 2 mentioned above.

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • A person who is more than 50 years and lesser than 70 years of age

  • A person who's MQ(Memory Quotient) score is within more than 70 and lesser than 120

Exclusion Criteria:
  • The patient who has past history related to memory

  • The patient who has Diabetes Mellitus

  • The person whose fasting blood sugar is more than 126mg/dL

  • The patients who has uncontrolled hypertension

  • The patient who has liver disorders

  • The patient whose AST(aspartate aminotransferase) or ALT(alanine aminotransferase) level is more than 60 IU/L(international units per liter)

  • The patients who has heart disorders (Angina pectoris, Myocardial infarction)

  • The patient who has past history related to excision of G-I tract excluding cecum

  • The patient who took drug or heal functional food within 4 weeks before screening

  • The patient who took decoction of herb within 4 weeks before screening

  • The patient who can't write or communicate

  • pregnant woman

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pusan National University Korean Medicine Hospital Yangsan Gyeongsangnamdo Korea, Republic of 626-770

Sponsors and Collaborators

  • Korean Medicine Hospital of Pusan National University

Investigators

  • Study Chair: In Lee, Doctor, Pusan National University Korean Medicine Hospital
  • Principal Investigator: Hye-lim Park, Master, Pusan National University Korean Medicine Hospital
  • Principal Investigator: Eunhye Jeong, bachelor, National Clinical Research Center for Korean Medicine Pusan National University Korean Medicine Hospital
  • Principal Investigator: Hana Lee, bachelor, National Clinical Research Center for Korean Medicine Pusan National University Korean Medicine Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Korean Medicine Hospital of Pusan National University
ClinicalTrials.gov Identifier:
NCT02401646
Other Study ID Numbers:
  • Memory_2015
First Posted:
Mar 30, 2015
Last Update Posted:
Mar 30, 2015
Last Verified:
Mar 1, 2015

Study Results

No Results Posted as of Mar 30, 2015